PRISM MEDICO AND PHARMACY LIMITED
Board Meeting Details
The Board of Directors meeting was held on Wednesday, August 12, 2026, at the company's registered office at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030. The meeting commenced at 1:30 PM and concluded at 3:30 PM.
Key Resolution Approved
The Board considered and approved the unaudited standalone financial results of the company for the quarter ended June 30, 2026, along with the Limited Review Report signed by the company's auditors.
Financial Results Overview (Quarter Ended June 30, 2026)
The unaudited standalone financial results show:
- Total Income: ₹65.73 lakh
- Net Profit/(Loss) for the period: Net loss of ₹5.83 lakh
- Tax expenses:
- Current tax: ₹11.78 lakh
- Deferred tax: ₹0.66 lakh
- MAT Credit: ₹(11.12) lakh
- Other comprehensive income: Not applicable (shown as ~)
- Total comprehensive income for the period: Net loss of ₹5.83 lakh
Capital Structure
- Paid-up equity share capital: ₹606.34 lakh (face value of shares to be indicated)
- Other equity (excluding revaluation reserve): ₹1,803.95 lakh
Auditor Review
Garg Mendiratta & Associates, Chartered Accountants, issued a limited review report on the financial results. The review was conducted in accordance with Standard on Review Engagement (SRE) 2410 issued by ICAI. The auditors stated that nothing has come to their attention that causes them to believe the financial results contain any material misstatement.
Authorization
Mr. Davender Singh, Director (DIN: 09447213), was authorized to sign the statement of accounts and take necessary actions to give effect to the resolution.